What is it used for?
Darvias contains darinaparsin, an organoarsenic anticancer medicine. The Japanese review covers adults with peripheral T-cell lymphoma that has returned or has not responded to previous treatment. The oncology team must confirm disease subtype and prior treatment history.Darvias contains darinaparsin, an organoarsenic anticancer medicine. The Japanese review covers adults with peripheral T-cell lymphoma that has returned or has not responded to previous treatment. The oncology team must confirm disease subtype and prior treatment history.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- darinaparsindarinaparsin
- Form and strength
- Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.
- Manufacturer / applicant
- Solasia Pharma K.K.Solasia Pharma K.K.
Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.
Safety and clinical review
The PMDA review identifies blood-cell suppression, infection, mental-status changes, nervous-system disorders and QT prolongation as safety topics for monitoring.The PMDA review identifies blood-cell suppression, infection, mental-status changes, nervous-system disorders and QT prolongation as safety topics for monitoring.
- Blood counts and infectionBlood counts and infection
- Neurologic and mental-status changesNeurologic and mental-status changes
- QT interval and other medicinesQT interval and other medicines
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is DARVIAS used for?
Darvias contains darinaparsin, an organoarsenic anticancer medicine. The Japanese review covers adults with peripheral T-cell lymphoma that has returned or has not responded to previous treatment. The oncology team must confirm disease subtype and prior treatment history.Darvias contains darinaparsin, an organoarsenic anticancer medicine. The Japanese review covers adults with peripheral T-cell lymphoma that has returned or has not responded to previous treatment. The oncology team must confirm disease subtype and prior treatment history.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of DARVIAS should I ask about?
Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.Injection 135 mg: powder reconstituted by healthcare professionals for intravenous infusion. The vial contains an overfill; the labelled withdrawable amount is 135 mg.
Read the primary sourceWhat determines the price of DARVIAS?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using DARVIAS?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.